wrong:
the ONLY data that really MATTERS is SAFETY: PERIOD!
The Efficacy Data is Pooled and you can tell very little..
ACCEPT..You can tell that the POOLED Data is BETTER than
BASELINE Alzheimers..Regardless of your stance on Data..
A2-73 is 100% better than Nothing!
The adaptive Phase 2s is designed to find MTD: Check 50 Mg, PK , check seen at 3Mg but 14 mg, more noticeable.
Look there are lots of Sigma 1 Agonists..but nothing like this.nothin!
All the positives are BILLION DOLLAR GRAVIES, not YEARS AWAY, but MONTHS,
because with A2-73 SAFETY profile and ALL the ANECDOTAL BENNIES,
the SECOND A2-73 becomes available for ANYTHING..
and I meand ANYTHING..CONSUMERS are going to BLOCKBUSTER
this Drug into the STRATOSPHERE..
Parkinson's, Depression, Insomnia, Alzheimrs delay..anti-convulsive,
Sigma 1 bennies not yet accounted for ..but..I believe Eyesight and heart issues will definitely come into play..
Any single ONE of these IND's makes AVXL a Multi-Billion Dollar Cash WOnderDrug..
But Anavex will just keep adding Multi-Billion Dollar IND's like
Country Sausage White Gray over Butter Milk Biscuits..The Good News will just keep coming IND after IND.
No one is waiting years..FDA will have A2-73 approval sooner than you think! Powerful People need drugs to brother..Powerful people don't want to die of Parkinsons or Alzheimers..You think THEY won't make FDA get them A2-73?
We will have A2-73 available by end of 1st Quarter of 2017!
Maybe even by end of THIS YEAR.
IF and that is a big IF, A2-73 keeps it's safety profile clean, squeaky,
and no additional side effects of any note are found..
A2-73 may be available because of and BY PUBLIC DEMAND even sooner in some countries..say in
Australia...A Painting or a Song speaks to people in a very basic language. LIFE is GOOD!
